MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0003602
Valens Molecules Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹100.32 Cr
Latest filing
Net profit · FY 2025
₹11.17 Cr
Net margin 11.1%
EBITDA · FY 2025
₹23.98 Cr
EBITDA margin 23.9%
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹10.88 Cr
Issued & subscribed
Open charges
₹73.97 Cr
Satisfied ₹67.38 Cr
Company age
32 yrs
Est. 1994
Employees · EPFO
178
Provident fund records
About Valens Molecules Private Limited
Data last updated:
Valens Molecules Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 02 November 1994 and has been in existence for over 32 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG1994PTC018680. Its GSTIN is 36AABCP4726A1ZU (Telangana). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹12 Cr and a paid-up capital of ₹10.88 Cr. It was formerly known as Posh Chemicals Pvt Ltd and Posh Chemicals Private Limited. It is led by directors including Cherukuri Surya Ratna Prasad (Managing Director) and Cherukuri Poshya (Whole-Time Director).
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 202 S.V.S Classic Residency 6 – 3 – 853/2 Ameerpet, Hyderabad, Telangana, India – 500016.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.32 Cr. For the same year it recorded a net profit of ₹11.17 Cr (net margin 11.1%) and EBITDA of ₹23.98 Cr (EBITDA margin 23.9%). Revenue has grown at a compounded annual rate (CAGR) of 1% over three years and 13% over five years.
The company has about 178 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Valens Molecules. As per MCA filings, the company has open charges of ₹73.97 Cr and satisfied charges of ₹67.38 Cr on record. Court records list 12 cases involving the company, including 10 filed by the company and 2 filed against it; 7 cases are pending. The company has 13 deals on record (11 secondary share transfers, 2 rights issues); the latest was in September 2021. Its 10 peer companies in the Pharma industry (API Manufacturers) are compared by revenue, 5 larger and 5 smaller; the largest is Avik Pharmaceutical Limited with revenue of ₹103.38 Cr. The company has 11 MSME Form 1 returns on record between 2019 and 2024, listing 161 overdue payments to 34 micro and small suppliers.
Valens Molecules Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0003602). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website valensmolecules.com.
Company Details of Valens Molecules Private Limited
CIN U24100TG1994PTC018680
Registration Number 018680
Incorporation Date 02 November 1994
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 15 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0003602
Name History of Valens Molecules Private Limited
Valens Molecules has undergone 2 name changes throughout its history. The company was previously known as Posh Chemicals Pvt Ltd, and Posh Chemicals Private Limited. The current legal name is Valens Molecules Private Limited.
| Company Name | Status |
|---|---|
| Valens Molecules Private Limited | Current |
| Posh Chemicals Pvt Ltd | Previous |
| Posh Chemicals Private Limited | Previous |
CIN History of Valens Molecules Private Limited
Valens Molecules has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG1994PTC018680, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG1994PTC018680 | Current |
| U40102AP1994PTC018680 | Previous |
| U40102TG1994PTC018680 | Previous |
| U24230AP1994PTC018680 | Previous |
Key People
Cherukuri Surya Ratna Prasad Managing Director Cherukuri Poshya Whole-Time Director Padmasree Cherukuri Whole-Time Director Recognitions & Rankings of Valens Molecules
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address202 S.V.S Classic Residency 6 – 3 – 853/2 Ameerpet, Hyderabad, Telangana, India – 500016
- IndustryPharma, API Manufacturers
Comprehensive company report
Valens Molecules Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Valens Molecules Private Limited
Valens Molecules operates one associated brand: Valens Molecules. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Valens Molecules is engaged in manufacturing APIs and specialty chemicals. | valensmolecules.com |
Business Activity of Valens Molecules Private Limited
The main business activity of Valens Molecules is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Valens Molecules Private Limited FY 2025 filings available
Valens Molecules Private Limited reported revenue of ₹100.32 Cr for FY 2025.
Revenue · FY 2025
₹100.32 Cr
Net profit · FY 2025
₹11.17 Cr margin 11.1%
EBITDA · FY 2025
₹23.98 Cr margin 23.9%
Compounded Annual Growth Rate (CAGR) of Valens Molecules Private Limited
Revenue CAGR growth
3 years · compounded
▲ 1%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 12%
5 years · compounded
▲ 24%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Valens Molecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹23.98 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹11.17 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Valens Molecules Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 23.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 11.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Valens Molecules are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Valens Molecules Private Limited
Valens Molecules has 6 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Cherukuri Poshya Also directs: Joie Ave LLP, Enpharm Private Limited | Whole-Time Director | 26 Aug 2006 | 20 Years 1 Months | Current |
| Padmasree Cherukuri | Whole-Time Director | 02 Nov 1994 | 31 Years 11 Months | Current |
| Cherukuri Ranga Prakash Also directs: Jeedimetla Effluent Treatment Limited. | Whole-Time Director | 24 Oct 2014 | 11 Years 11 Months | Current |
| Rahul Yalamanchili Also directs: Enpharm Private Limited, Georgetown Pharma Private Limited | Whole-Time Director | 07 Jan 2013 | 13 Years 9 Months | Current |
| Mulukutla Sambasiva Sastry | Director | 28 Aug 2001 | 25 Years 1 Months | Current |
| Cherukuri Surya Ratna Prasad | Managing Director | 02 May 1995 | 31 Years 5 Months | Current |
Peer Comparison of Valens Molecules Private Limited
Valens Molecules Private Limited is compared with the companies closest to it by revenue in the Pharma industry (API Manufacturers). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Avik Pharmaceutical Limited | ₹103.38 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Sriven Pharmachem India Private Limited | ₹102.76 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Hyderabad, Telangana, India |
| Vineet Life Sciences Limited | ₹101.85 Cr (FY 2024) | •••• | •••• | 48.0% | •••• | Hyderabad, Telangana, India |
| Sna Healthcare Private Limited | ₹101.57 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| Sarv Bio Labs Private Limited | ₹101.4 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Himachal Pradesh, India |
| Valens Molecules Private Limited this company | ₹100.32 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Ketul Chem Private Limited | ₹98.92 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Mumbai, Maharashtra, India |
| Warren Remedies Private Limited | ₹98.74 Cr (FY 2025) | •••• | •••• | 2320.0% | •••• | Aurangabad, Maharashtra, India |
| Benova Labs Private Limited | ₹98.59 Cr (FY 2025) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Teena Labs Limited | ₹96.94 Cr (FY 2024) | •••• | •••• | -46.0% | •••• | Hyderabad, Telangana, India |
| B G P Healthcare Private Limited | ₹95.66 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ankleshwar, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Valens Molecules by revenue in the Pharma industry (API Manufacturers), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Valens Molecules Private Limited
Valens Molecules Private Limited is audited by C.M.Rao & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| C.M.Rao & Co. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Valens Molecules Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Valens Molecules Private Limited
Open charges
₹73.97 Cr
Satisfied charges
₹67.38 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2025 | Hdfc Bank Limited | ₹40 Lakh | Open |
| 20 Jun 2025 | Hdfc Bank Limited | ₹13.14 Lakh | Open |
| 29 Mar 2025 | Others | ₹1.1 Cr | Open |
| 22 May 2024 | Hdfc Bank Limited | ₹97 Lakh | Open |
| 21 Dec 2023 | Others | ₹1.06 Cr | Open |
Total charge records: 23 View all charges
Deals & Funding of Valens Molecules Private Limited
Valens Molecules Private Limited has 13 deals on record (11 secondary share transfers, 2 rights issues); the latest was in September 2021.
Total deals
13
Secondary share transfers
11
Rights issues
2
Deals on record (5 of 13)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Apr 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2020 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Premium access
Full deal history
All 13 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Valens Molecules Private Limited
Valens Molecules Private Limited has 12 court cases on record: 10 filed by Valens Molecules, 2 filed against it. 7 cases are pending and 5 are disposed.
Total cases
12
Filed by the company
10
Filed against the company
2
Pending
7
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 2 | 5 |
| District courts | 2 | 0 | 2 |
| Supreme Court | 2 | 0 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Court case (WP(PIL)) | Filed against the company | Pending |
| District court, Kamareddy, Telangana | Civil suit | Filed by the company against an individual | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Telangana State Southern Power Distribution Company Limited and 2 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against The State of Telangana and 4 others | Pending |
| High Court, TELANGANA | Writ petition | Filed by the company against Telangana State Southern Power Distribution Company Limited and 4 Others and 4 others | Pending |
Premium access
Full case history
All 12 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Valens Molecules Private Limited
Valens Molecules Private Limited has 11 MSME Form 1 returns on record between 2019 and 2024, listing 161 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pragati Polyplast India Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Evershine Tools Traders | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
| Srse Cleanrooms Technologies Private Limited | •••• | •••• | •••• |
Premium access
Full MSME payment history
Every supplier, amount and due date from all 11 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Valens Molecules Private Limited
Valens Molecules Private Limited has a workforce of 178 employees as of Apr 04, 2024.
Employee count
178
Active EPFO establishments
1
Employee growth
-6.81%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Valens Molecules Private Limited
Valens Molecules Private Limited has 13 board changes on record since 1994: 6 appointments and 7 cessations. The latest: Ashok Prabhakar Mayekar ceased to be Director on 28 Apr 2019.
AGM
Valens Molecules Private Limited last Annual general meeting of members was held on 15 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 101144154 was registered on 21 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101124269 was registered on 20 Jun 2025.
Charges
A charge registered on 28 Jan 2021 via Charge ID 100417397 with Others was fully satisfied on 28 Apr 2025.
Filing
Valens Molecules Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Others amounted to Rs. 1.10 Cr with Charge ID 101107967 was registered on 29 Mar 2025.
Charges
A charge registered on 12 Sep 2019 via Charge ID 100299076 with Others was fully satisfied on 21 Jan 2025.
Charges
A charge registered on 31 Dec 2019 via Charge ID 100324378 with Others was fully satisfied on 09 Jul 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.97 Cr with Charge ID 100930047 was registered on 22 May 2024.
Charges
A charge with Others amounted to Rs. 1.06 Cr with Charge ID 100844329 was registered on 21 Dec 2023.
Charges
A charge with Others amounted to Rs. 0.30 Cr with Charge ID 100819480 was registered on 03 Nov 2023.
Charges
A charge registered on 16 Oct 2017 via Charge ID 100133243 with Others was fully satisfied on 07 Jun 2023.
43 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Valens Molecules Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Valens Molecules Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Valens Molecules Private Limited
Valens Molecules has 3 GST registrations: 3 active.
Total GSTINs
3
Active
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCP4726A1ZU | Telangana | Active | 01 Jul 2017 |
| 36AABCP4726A2ZT | Telangana | Active | 27 Mar 2025 |
| 37AABCP4726A1ZS | Andhra Pradesh | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Valens Molecules Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Valens Molecules Private Limited
Valens Molecules is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 02 November 1994 (32+ years old) and is registered under CIN U24100TG1994PTC018680.
Valens Molecules reported revenue of ₹100.32 Cr for FY 2025.
Valens Molecules has 6 current directors:
- Cherukuri Surya Ratna Prasad - Managing Director
- Cherukuri Poshya - Whole-Time Director
- Padmasree Cherukuri - Whole-Time Director
- Cherukuri Ranga Prakash - Whole-Time Director
- Rahul Yalamanchili - Whole-Time Director
- Mulukutla Sambasiva Sastry - Director
Valens Molecules reported a net profit of ₹11.17 Cr (net margin 11.1%) and EBITDA of ₹23.98 Cr (EBITDA margin 23.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Valens Molecules is 1% over three years and 13% over five years. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Valens Molecules is 36AABCP4726A1ZU, registered in Telangana. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 36AABCP4726A2ZT (Telangana), 37AABCP4726A1ZS (Andhra Pradesh).
The CIN (Corporate Identification Number) of Valens Molecules is U24100TG1994PTC018680. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Valens Molecules has 12 court cases on record: 10 filed by the company and 2 filed against it. 7 are pending. Most are in the high courts.
Valens Molecules was incorporated on 02 November 1994, making it 32+ years old. It is registered with the Registrar of Companies, Hyderabad.
Valens Molecules has 13 deals on record (11 secondary share transfers, 2 rights issues); the latest was in September 2021.
The peers of Valens Molecules by revenue are Avik Pharmaceutical Limited, Sriven Pharmachem India Private Limited, Vineet Life Sciences Limited, Sna Healthcare Private Limited, Sarv Bio Labs Private Limited and 5 more, all in the Pharma industry (API Manufacturers).
Ashok Prabhakar Mayekar ceased to be Director on 28 Apr 2019. Cherukuri Poshya ceased to be Director on 01 Apr 2019. Mulukutla Sambasiva Sastry ceased to be Whole-Time Director on 01 Apr 2019. Valens Molecules has 13 board changes on record in total.